The poisoned patient with altered consciousness. Controversies in the use of a 'coma cocktail' - PubMed (original) (raw)
Review
. 1995 Aug 16;274(7):562-9.
Affiliations
- PMID: 7629986
Review
The poisoned patient with altered consciousness. Controversies in the use of a 'coma cocktail'
R S Hoffman et al. JAMA. 1995.
Abstract
Objective: In the assessment and management of the potentially poisoned patient with altered consciousness, the most consequential and controversial interventions occur during the first 5 minutes of care. In this review article, the risks and benefits of standard diagnostic and therapeutic interventions are presented to guide clinicians through this critical period of decision making.
Data sources: Data for discussion were obtained from a search of English-language publications referenced on MEDLINE for the years 1966 to 1994. Older literature was included when pertinent. Search terms included poisoning, overdose, toxicity, naloxone, glucose, thiamine, and flumazenil.
Study selection: Only large trials were used for determinations of diagnostic utility and efficacy. Small trials, case series, and case reports were reviewed extensively for adverse effects.
Data extraction and synthesis: Trials were reviewed for overall methodology, inclusion and exclusion criteria, sources of bias, and outcome.
Conclusion: Analysis favors empirical administration of hypertonic dextrose and thiamine hydrochloride to patients with altered consciousness. Although rapid reagent test strips can be used to guide this therapy, they are not infallible, and they fail to recognize clinical hypoglycemia that may occur without numerical hypoglycemia. Administration of naloxone hydrochloride should be reserved for patients with signs and symptoms of opioid intoxication. Flumazenil is best left for reversal of therapeutic conscious sedation and rare select cases of benzodiazepine overdose.
Similar articles
- Reappraisal of the "coma cocktail". Dextrose, flumazenil, naloxone, and thiamine.
Doyon S, Roberts JR. Doyon S, et al. Emerg Med Clin North Am. 1994 May;12(2):301-16. Emerg Med Clin North Am. 1994. PMID: 8187685 Review. - The coma cocktail: indications, contraindications, adverse effects, proper dose, and proper route.
Bartlett D. Bartlett D. J Emerg Nurs. 2004 Dec;30(6):572-4. doi: 10.1016/j.jen.2004.09.002. J Emerg Nurs. 2004. PMID: 15565045 Review. No abstract available. - Coma induced by intoxication.
Buylaert WA. Buylaert WA. Acta Neurol Belg. 2000 Dec;100(4):221-4. Acta Neurol Belg. 2000. PMID: 11233676 Review. - Flumazenil, naloxone and the 'coma cocktail'.
Sivilotti ML. Sivilotti ML. Br J Clin Pharmacol. 2016 Mar;81(3):428-36. doi: 10.1111/bcp.12731. Epub 2015 Sep 21. Br J Clin Pharmacol. 2016. PMID: 26469689 Free PMC article. Review. - Flumazenil: a benzodiazepine antagonist.
Hoffman EJ, Warren EW. Hoffman EJ, et al. Clin Pharm. 1993 Sep;12(9):641-56; quiz 699-701. Clin Pharm. 1993. PMID: 8306565 Review.
Cited by
- The Devil Is in the Details but the Details Are Not in NHAMCS.
Connors NJ, Nelson LS. Connors NJ, et al. J Med Toxicol. 2016 Jun;12(2):145-7. doi: 10.1007/s13181-016-0541-0. Epub 2016 Apr 15. J Med Toxicol. 2016. PMID: 27083902 Free PMC article. No abstract available. - Safety of Physostigmine for Pediatric Antimuscarinic Poisoning.
Huber S, Avera R, Penfound S, Overberg A, Nañagas K. Huber S, et al. J Med Toxicol. 2024 Sep;20(3):263-270. doi: 10.1007/s13181-024-00988-0. Epub 2024 Jan 24. J Med Toxicol. 2024. PMID: 38265619 - Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area.
Seal KH, Downing M, Kral AH, Singleton-Banks S, Hammond JP, Lorvick J, Ciccarone D, Edlin BR. Seal KH, et al. J Urban Health. 2003 Jun;80(2):291-301. doi: 10.1093/jurban/jtg032. J Urban Health. 2003. PMID: 12791805 Free PMC article. - Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study.
Worthington N, Markham Piper T, Galea S, Rosenthal D. Worthington N, et al. Harm Reduct J. 2006 Jul 5;3:19. doi: 10.1186/1477-7517-3-19. Harm Reduct J. 2006. PMID: 16822302 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical